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SHORT COMMUNICATION
Screening of ninety herbal products of commercial interest as potential
ingredients for phytocosmetics
Mariacaterina Lianza, Manuela Mandrone, Ilaria Chiocchio, Paola Tomasi, Lorenzo Marincich and Ferruccio Poli
Department of Pharmacy and Biotechnology, University of Bologna, Bologna, Italy
ABSTRACT
Elastase and tyrosinase are important targets both for cosmetics and for dermatological disorders. In this
work, ninety herbal products were tested as inhibitors of these two enzymes. Eleven extracts resulted
strongly active. Four out of them (Camellia sinensis, Ginkgo biloba, Rhodiola rosea, Vitis vinifera) inhibited
both enzymes, five (Glycyrrhiza glabra, Ribes nigrum, Rheum officinale, Salvia officinalis, Tilia platyphyllos)
were active against tyrosinase only, and two (Ceterach officinarum and Cinnamomum zeylanicum) proved
selectively active against elastase. The IC50 ranged from 3.1 to 104.9lg/mL and 19.3 to 164.3lg/mL,
against elastase and tyrosinase, respectively. The most active extracts resulted enriched in flavonoids
(from 1.47 to 56.47mg RE/g of extract) and phenolics (from 37.43 to 123.56mg GAE/g of extract), indicat-
ing also an antioxidant potential. Finally, a positive correlation between enzymatic bioactivities and phen-
olic content was also established.
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The demand for new skincare ingredients, especially based on nat-
ural products, strongly increased during the last few decades1,2.
Plant bioactive metabolites are most of the time free from harmful
side effects, hence, great importance is given to the research of nat-
urally occurring anti-ageing agents. Several plants proved to be
effective to slow down skin ageing3, acting as antioxidants, protect-
ing skin against solar radiations4, and/or modulating the activity of
enzymes involved in the ageing processes5, among which elastase
(Ela) and tyrosinase (Tyr) are of remarkable importance.
Elastase activity increases significantly with age and after
chronic UV-B irradiation 6, resulting in sagging due to loss of skin
elasticity, thus inhibition of this enzyme is valuable strategy to
slow down the intrinsic and extrinsic ageing processes7.
Tyrosinase is responsible for skin hyper-pigmentation, as in case
of melasma, freckles, ephelide and senile lentingines8 being an
important target for skin-whitening agents.
This work aimed at identifying herbal products endowed with
Tyr and/or Ela inhibitory activity (IA), thus potential anti-ageing
agents. The bioactivity screening was carried out on extracts
obtained from ninety commercial plants, widely used as ingre-
dients for herbal preparations, including botanicals, herbal teas,
and food supplements9,10. Considering the importance of poly-
phenols as antioxidant, the total phenolic and flavonoid content
of the extracts was also determined and their content was also
statistically correlated to the percentages of enzymatic inhibition.
2. Methods and materials
2.1. Plant material and extracts preparation
Plant samples were kindly supplied by Biokyma S.r.l., Anghiari (AR)
Italy, and identified by Dr. Franco Maria Bini and vouchers of
crude drugs were deposited in Department of Pharmacy and
Biotechnology, University of Bologna (via Irnerio 42, Bologna, Italy)
and reported in Table 1.
Thirty mg of dried and powdered plant material were extracted
by sonication for 30min using 1.5mL of EtOH/H2O (1:1). Crude
extracts were obtained as reported by Chiocchio et al.11.
2.2. Enzyme inhibitory assays, total phenolic and
flavonoid content
The assays were performed according to the methods described
by Chiocchio et al.11, with slight modification for elastase inhibi-
tory assay, where N-succinyl-Ala-Ala-Pro-Phe was used as substrate
and p-phenylmethylsulfonyl fluoride (PMSF) from 1 to 250 lg/mL
was used as positive control. For PMSF the assay was performed
in 5% DMSO, thus, a proper negative control in the same condi-
tions was used for the IC50 calculation.
The kinetic parameters for the enzymatic reactions in the assay
conditions were KM ¼ 0.2mM for both enzymes and Vmax ¼
6 lmol/min for elastase and Vmax ¼ 10 lmol/min for tyrosinase.
The assays for phenolic and flavonoid contents were performed
in Spectrophotometer (Jasco V-530) as described by
Chiocchio et al.11.
2.3. Statistical analysis
Values were expressed as the mean± SD of three independent
experiments (each one performed in duplicate). Statistical analyses
were performed using R Studio software (version 1.1.463) based
on the R software version 3.5.212.
Samples were compared by one-way analysis of variance
(ANOVA) performed with “aov” function using “stats” package,
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Table 1. Plants tested in this study, including their botanical name, family, organ/s used, voucher number, percentage of tyrosinase (Tyr IA %). and elastase inhibi-
tory (Ela IA %) activity at 50 lg/mL, total phenolics (TPC) and flavonoids (TFC) content expressed in mg of gallic acid (GA) equivalent/mg of extract and mg of rutin
(R) equivalent/mg of extract respectively.
Plant name Family Plant part Voucher number Tyr IA % Ela IA %
TPC (mg AG eq/mg
extract)
TFC (mg R eq/mg
of extract)
Ananas comosus (L.) Merr. Bromeliaceae Stem PU03555T 14 2 13.6 ± 0.8 0.8 ± 0.4
Andrographis paniculata
(Burm. F.) Nees
Acanthaceae Whole plant PS16409T 14 0 60.3 ± 2.1 24.4 ± 2.2
Angelica archangelica L. Apiaceae Roots PFU03844C 10 2 9.9 ± 0.3 0.4 ± 0.1
Angelica sinensis (Oliv.) Diels Apiaceae Roots PU04044C 7 0 4.7 ± 0.1 0.7 ± 1.6
Arctium lappa L. Compositae Roots PU06744C 24 7 35.0 ± 0.1 6.4 ± 0.3
Arnica montana L. Compositae Fruits PZ05222I 24 8 49.5 ± 3.6 19.3 ± 0.3
Artemisia dracunculus L. Compositae Leaves PZ19911T 16 6 60.4 ± 1.5 19.5 ± 2.3
Astragalus
propinquus Schischkin
Leguminosae Roots PU06244C 17 6 9.8 ± 0.3 0.0 ± 0.0
Avena sativa L. Poaceae Aerials parts PS06309T 8 14 25.6 ± 1.3 8.8 ± 0.2
Berberis vulgaris L. Berberidaceae Bark PU07188T 13 2 30.5 ± 12.1 62.0 ± 3.6
Boswelia sacra Flueck Burseraceae Grains PU30703I 19 0 1.4 ± 0.0 0.5 ± 0.7
Camellia sinensis (L.) Kuntze Theaceae Leaves PU61111I 43 39 59.8 ± 3.7 26.2 ± 1.6
Capsella bursa-pastoris
(L.) Medik
Brassicaceae Flowered tops PU08933T 8 0 40.8 ± 0.7 34.0 ± 1.6
Capsicum annuum L. Solanaceae Fruits PU46555I 0 0 29.0 ± 2.2 7.0 ± 0.3
Ceterach officinarum Willd. Aspleniaceae Aerials parts PFU59533T 24 63 84.7 ± 2.4 13.7 ± 0.5
Cichorium intybus L. Compositae Roots BIOU15344C 0 0 6.8 ± 0.7 4.6 ± 0.2
Cinchona succirubra Pav. Rubiaceae Barks PU15188C 23 16 82.9 ± 1.5 3.0 ± 0.1
Cinnamomum
zeylanicum Blume
Lauracee Barks PU11188T 17 35 53.5 ± 1.5 5.3 ± 1.7
Citrus aurantium L. var.
dulcis Hayne
Rutaceae Flowers PFU04922I 6 5 31.7 ± 0.7 14.2 ± 0.9
Citrus aurantium L. var.
dulcis Hayne
Rutaceae Zests PFU04967T 8 11 21.4 ± 0.4 3.8 ± 0.4
Coffea robusta L. Rubiaceae Grains PU09603C 23 22 100.9 ± 7.1 3.1 ± 0.0
Coriandrum sativum L. Apiaceae Fruits PFU17955I 0 0 21.6 ± 0.5 3.1 ± 0.2
Crataegus
rhipidophylla Gand.
Rosaceae Flowers and leaves PU08112T 23 17 77.9 ± 1.6 27.5 ± 2.5
Cucurbita pepo L. Cucurbitaceae Seeds PU68277I 0 0 4.7 ± 0.3 0.2 ± 0.3
Curcuma longa L. Zingiberaceae Rhizomes PU19344C 9 4 5.8 ± 0.1 3.3 ± 0.0
Cynara scolymus L. Compositae Leaves PU11511T 22 19 83.7 ± 2.6 24.7 ± 0.5
Cynodon dactylon (L.) Pers. Poaceae Rhizomes PU29499C 10 0 9.1 ± 0.2 0.9 ± 0.1
Dioscorea villosa L. Dioscoreaceae Roots PS20044P 11 1 8.4 ± 0.2 0.0 ± 0.0
Echinacea angustifolia DC. Compositae Roots PFZ20544C 14 21 22.2 ± 1.4 2.9 ± 0.2
Echinacea pallida
(Nutt.) Nutt.
Compositae Roots PU20444C 7 0 21.5 ± 0.7 5.2 ± 0.4
Echinacea purpurea
(L.) Moench.
Compositae Roots PU20644C 12 0 42.1 ± 0.6 11.9 ± 0.2
Eleutherococcus senticosus
(Rupr. & Maxim) Maxim.
Araliaceae Roots PU21144C 10 8 31.5 ± 3.9 1.5 ± 0.1
Elymus repens (L.) Gould
subsp. repens
Poaceae Rhizomes PU29999C 17 3 13.8 ± 0.5 0.3 ± 0.0
Epilobium angustifolium L. Onagraceae Flowered tops PFU21933T 18 12 97.9 ± 0.9 22.5 ± 0.3
Epilobium
parviflorum Schreb.





BIOD3744I 19 13 31.6 ± 0.4 29.8 ± 0.4
Foeniculum vulgare Miller Apiaceae Fruits PU25677I 14 0 37.3 ± 0.8 8.8 ± 0.3
Fumaria officinalis L. Papaveraceae Flowered tops BIOF26733T 11 17 41.1 ± 3.7 17.6 ± 0.6
Ginkgo biloba L. Ginkgoaceae Leaves PU28911T 38 34 79.8 ± 1.5 25.8 ± 1.0
Glycyrrhiza glabra L. Leguminosae Roots PU34344C 59 2 37.4 ± 1.2 30.4 ± 2.0
Handroanthus impetiginosus
(Mart. ex DC.) Mattos
Bignoniaceae Barks PU60244C 12 4 27.6 ± 1.6 2.7 ± 0.1
Harpagophytum
procumbens DC.
Pedaliaceae Roots PU05544C 23 4 44.5 ± 0.0 2.4 ± 0.1
Helichrysum italicum G. Don Compositae Flowered tops PU21333T 20 6 88.1 ± 0.8 27.8 ± 1.6
Hibiscus sabdariffa L. Malvacee Flowers BIOU31922T 13 0 27.8 ± 0.6 4.4 ± 0.0
Humulus lupulus L. Cannabaceae Flowers PS36722I 15 0 32.0 ± 0.5 6.3 ± 0.2
Hyssopus officinalis L. Lamiaceae Flowers and leaves PFU31322I 18 3 69.9 ± 2.3 2.1 ± 0.4
Ilex paraguariensis A. St. Hil. Aquifoliaceae Flowered tops PU38533T 20 0 113.8 ± 6.9 18.0 ± 0.2
Lavandula angustifolia Mill. Lamiaceae Flowers PFU32722I 11 0 71.9 ± 3.4 6.9 ± 0.5
Lepidium meyenii Walp. Brassicaceae Roots BIOZ37044P 9 0 8.3 ± 0.6 0.2 ± 0.0
Malva sylvestris L. Malvaceae Leaves BIOU37311T 3 0 41.2 ± 1.9 26.8 ± 2.5
Matricaria chamomilla L. Compositae Flowers PFU10522I 26 0 54.2 ± 3.8 36.4 ± 1.2
Melissa officinalis L. Lamiaceae Leaves PU38911T 23 12 124.3 ± 7.6 7.5 ± 0.1
Mentha x piperita L. Lamiaceae Leaves PU39511T 18 4 113.9 ± 9.1 60.5 ± 5.2
Menyanthes trifoliata L. Menyanthaceae Leaves PU62711T 11 3 30.6 ± 2.2 13.3 ± 1.1
Moringa oleifera Lamk. Moringaceae Leaves PU40711T 6 12 54.1 ± 0.9 22.6 ± 3.1
Olea europaea L. Oleaceae Leaves BIOF42911T 9 0 76.5 ± 0.3 14.3 ± 1.4
Orthosiphon aristatus
(Blume) Miq.
Lamiaceae Leaves PU43711T 12 7 51.7 ± 0.7 9.6 ± 1.4
Panax ginseng C. A. Mey. Araliaceae Roots PC29144T 0 0 8.6 ± 0.2 0.1 ± 0.1
Papaver rhoeas L. Papaveraceae Petals PFU44708T 15 10 75.1 ± 2.5 39.2 ± 1.3
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followed by Tukey’s Honestly Difference (HSD) post-hoc test using
TukeyHSD function presents in “stats” package13, considering sig-
nificant difference at p values < 0.05. In order to determine the
correlation between total phenolic and flavonoid content and
enzymatic activities, Pearson correlation coefficient (r) was eval-
uated with “cor.test” function using “stats” package14.
3. Results and discussion
A first bioactivity screening was carried out on extracts at the
fixed concentration of 50lg/mL. The obtained results (Table 1)
allowed the selection of eleven extracts, whose IA was higher
than 30%, namely: Camellia sinensis Kuntze (leaves) (CCS), Ceterach
officinarum D.C. (aerials parts) (COF), Cinnamomum zeylanicum
Nees (barks) (CZE), Ginkgo biloba L. (leaves) (GBI), Glycyrrhiza gla-
bra L.(roots) (GGL), Rheum officinale Baill. (rhizomes) (ROF),
Rhodiola rosea L. (roots) (RRO), Ribes nigrum L. (leaves) (RNI), Salvia
officinalis L. (leaves) (SOF), Tilia platyphyllos Scop. (aerial parts)
(TPL) and Vitis vinifera L. (leaves) (VVI). Among them, four resulted
active against both enzymes (CSI, GBI, RRO, VVI), five showed Tyr
IA only (GGL, RNI, ROF, SOF, TPL), and two only Ela IA (COF, CZE).
The IC50 values of Ela IA of the six selected samples ranged
from 3.1 ± 1.9 to 104.9 ± 2.1lg/mL (Figure 1(A)), and among them,
RRO and COF resulted the most potent elastase inhibitors (EI).
These results are particularly promising, considering that the posi-
tive control (PMSF) used for Ela inhibitory assay showed IC50 of
42lg/mL (241 lM). The extract of COF resulted the most potent
Ela inhibitor of this screening, with an IC50 value of 26 ± 0.3mg/mL.
Regarding VVI, this study reported for the first time its activity
against Ela, while its Tyr IA was already known15. Finally, this study
provides new bioactivity data also for CZE, which is generally
used as a food additive for its taste and scent. In particular, CZE
expressed a selective Ela IA, showing an IC50 value of
104.9 ± 2.1 mg/mL, providing evidence in favour of the use of this
herbal product also for skin care.
Concerning Tyr IA, the IC50 values calculated for the nine active
extracts ranged from 19.3 ± 1.2 to 164.3 ± 25.5 lg/mL (Figure 1(B)),
and the highest IA was shown by CSI, GGL, RNI, RRO, VVI.
Flowers and bracts of TPL are widely used in southern Europe
folk medicine16, our results highlighted its strong Tyr IA, indicating
a new potential use of this renowned herbal product as cosmetic
ingredient. According to Chen et al.17, RRO acetone extract exerts
Tyr IA with an IC50 of 181.8 ± 11.0 mg/mL, resulting remarkably less
active then the hydroalcoholic extract tested in this study (IC50 of
19.26 ± 1.16 mg/mL). This difference may be due both to the differ-
ent assay conditions, particularly incubation time and types of
substrate, and to the diverse extraction method employed, since
solvent properties strongly affect compounds extraction and con-
sequently the inhibitory effect of a plant extract18,19. The same
reasons could justify also the significant difference in Tyr IA found
for CSI extract by Chen et al.17 (IC50 ¼ 232.5 ± 3.3lg/mL) and the
one obtained in this study (IC50 ¼ 66.04 ± 1.75 lg/mL).
Among the active principles contained in RRO tyrosol and sali-
droside are known to posses Tyr IA activity20. Regarding GGL, it is
Table 1. Continued.
Plant name Family Plant part Voucher number Tyr IA % Ela IA %
TPC (mg AG eq/mg
extract)
TFC (mg R eq/mg
of extract)
Paullinia sorbilis Mart. Sapindaceae Seeds PU30577I 22 6 51.1 ± 0.5 4.1 ± 0.1
Peumus boldus Molina Monimiaceae Leaves BIOU08511T 17 2 88.1 ± 0.4 23.8 ± 0.5
Piper nigrum L. Piperacee Grains PU46303I 3 10 35.4 ± 0.4 6.4 ± 0.0
Plantago major L. Plantaginaceae Leaves PFU46711T 12 5 59.9 ± 0.8 10.6 ± 2.0
Ptychopetalum
olacoides Benth.
Olacaceae Wood PU41104T 14 8 33.0 ± 0.7 2.6 ± 0.3
Rheum officinale Baill. Polygonaceae Rhizomes PFU51799C 30 20 82.4 ± 2.9 16.1 ± 0.2
Rhodiola rosea L. Crassulaceae Roots PU53244T 75 86 123.6 ± 18.6 1.5 ± 1.2
Ribes nigrum L. Grossulariaceae Leaves BIOF52511T 48 19 96.4 ± 5.9 29.9 ± 0.8
Rosa canina L. Rosaceae Cinorrodes/seeds PFU53310I 0 0 75.7 ± 1.1 1.6 ± 0.0
Rubus idaeus L. Rosaceae Leaves PU54711T 7 10 127.2 ± 6.7 33.9 ± 1.5
Salvia officinalis L. Lamiaceae Leaves BIOF56111T 43 9 95.9 ± 3.4 43.9 ± 1.0
Sambucus nigra L. Adoxaceae Flowers BIOF56322I 19 9 80.1 ± 2.3 191.7 ± 2.2
Satureja montana L. Lamiaceae Leaves PU56911I 21 0 84.2 ± 1.1 32.9 ± 0.2
Schisandra chinensis
Turcz. Baill.
Schisandraceae Fruits PZ57455I 12 16 10.1 ± 0.4 0.7 ± 0.0
Senna alexandrina Mill. Leguminosae Leaves PU58311T 12 21 31.9 ± 1.1 37.5 ± 0.1
Serenoa repens (W.
Bratram) Small
Arecaceae Fruits PU58755T 12 17 25.7 ± 1.4 3.0 ± 0.2
Silybum marianum
(L.) Gaert.
Compositae Fruits BIOU12155I 27 0 44.2 ± 2.4 2.3 ± 0.4
Smilax aristolochiifolia Mill. Smilacaceae Roots PU55944C 0 0 20.4 ± 1.4 3.4 ± 0.5
Theobroma cacao L. Malvaceae Beans PS18677I 24 15 91.3 ± 6.1 3.1 ± 0.1
Tilia platyphyllos Scop. Malvaceae Flowers and bracts PU61533T 35 24 91.2 ± 1.3 13.9 ± 0.2
Trifolium pratense L. Leguminosae Fruits PU62822I 22 4 69.8 ± 23.7 25.3 ± 0.1
Trigonella foenum-
graecum L.
Leguminosae Seeds PU25377I 0 0 25.2 ± 1.1 15.3 ± 0.3
Turnera diffusa Willd.
ex Schult.
Passifloraceae Leaves PZ19711T 17 13 58.7 ± 2.6 50.6 ± 0.7
Uncaria tomentosa (Willd. ex
Schult.) DC.
Rubiaceae barks PU63288T 16 4 40.4 ± 0.5 2.6 ± 0.4
Urtica dioica L. Urticaceae Leaves PU43911T 5 0 56.0 ± 1.4 16.7 ± 0.4
Vaccinium myrtillus L. Ericaceae Leaves PU40511T 21 12 116.5 ± 2.0 43.6 ± 0.6
Valeriana officinalis L. Caprifoliaceae Roots PU63744C 16 0 13.6 ± 0.5 2.2 ± 0.3
Verbascum thapsus L. Scrophulariaceae Fruits PU64122I 7 0 9.7 ± 0.9 23.4 ± 1.7
Viscum album L. Santalaceae Leaves and twigs PU65711I 10 9 21.9 ± 0.1 5.2 ± 0.1
Vitex agnus castus L. Lamiaceae Fruits PU01355I 8 5 49.5 ± 1.2 22.9 ± 0.5
Vitis vinifera L. Vitaceae Leaves PU66711T 42 36 81.1 ± 2.7 56.5 ± 1.5
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traditionally and commercially used for skin whitening formula-
tions. The pyranoisoflavan glabridin showed promising anti-tyro-
sinase activity on melanoma cells and anti-melanogenesis activity
on B16 murine melanoma cells. Additionally, reduced pigmenta-
tion and inflammation induced by UVB on guinea-pig skins at
0.5% w/v concentration21. Licuraside, isoliquiritin and licochalcone
A also showed competitive inhibition on monophenolase activity
of mushroom tyrosinase22, conversely, glabrene and isoliquiritige-
nin can inhibit both the reactions catalysed by tyrosinase23.
C. sinensis is widely used in skin care preparations for its pecu-
liar catechines having significant antioxidant, anti-inflammatory
and UV-protection activities. Moreover, tea polyphenols, i.e.
(–)-epicatechin 3-O-gallate, (–)-gallocatechin 3-O-gallate, and
(–)-epigallocatechin 3-O-gallate (EGCG) are known to possess tyro-
sinase inhibitory potential24.
Due to its popularity as cosmetic ingredient, CSI can be consid-
ered a further positive control in this screening. On this basis COF
and RRO resulted very promising Ela inhibitors, being significantly
stronger than CSI. While in the case of TI, GGL, RRO, VVI, and RNI
showed an activity comparable to CSI.
Considering the antioxidant properties of polyphenols and fla-
vonoids and their reported activity against several enzymes25,26,
the total content of these classes of metabolites was evaluated in
all the selected samples (Table 1). Pearson correlation test was
performed to correlate the percentage of IA (showed by extracts
at 50 mg/mL) to the phenolic and flavonoids content respectively.
A moderate positive correlation was found between the IA and
the total phenolic content, the highest with TI (r¼ 0.4965449 and
p values ¼ 6.442e-07). A similar correlation trend was found in
our previous work11, supporting the importance of phenolics in
this biological activity. Conversely, for total flavonoid content no
correlation was observed with both inhibitory activities. However,
the eleven most active extracts resulted interestingly enriched in
flavonoids (ranging from 1.47 to 56.47mg RE/g of extract) and
phenolics (ranging from 37.43 to 123.56mg GAE/g of extract),
which indicate also a potential activity as antioxidant agents.
5. Conclusions
Eleven extracts out of ninety resulted promisingly active against
enzymes of cosmetic interest, showing IC50 values comparable or
even lower than positive controls (PMSF and kojic acid). In particu-
lar, four out of them inhibited both enzymes, five tyrosinase only
and two acted prominently only against elastase. For C. officina-
rum (aerial parts), C. zeylanicum (barks), R.nigrum (leaves), T. platy-
phyllos (flowers and bracts) and V. vinifera (leaves) the activity
against one or both enzymes was reported for the first time, pro-
viding a new perspective for the use of these plants. Among
them, C. officinarum (aerial parts) resulted one of the most potent
EI, while R. nigum (leaves) and V. vinifera (leaves) showed the
highest inhibitory activity against tyrosinase. The plants active
against both enzymes (C. sinensis, G. biloba, R. rosea, V. vinifera)
are potentially useful to develop cosmetics endowed with both
skin-whitening and anti-wrinkles effect. The five plants active
against tyrosinase only (G. glabra, R. nigrum, R. officinalis, S. offici-
nalis, T. platyphyllos) are suitable for skin whitening agents, and
the two active only against elastase (C. officinarum and C. zeylani-
cum) are interesting for selective anti-wrinkles cosmetics.
Moreover, these plants resulted also enriched in polyphenols and
flavonoids, conferring them additional antioxidant properties rele-
vant for cosmetic ingredients and the total phenolic content
showed a linear correlation with the enzymatic inhibi-
tory activities.
Further biological and phytochemical studies are ongoing on
the selected plants in order to identify the metabolites responsible
for the observed biological activities.
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Figure 1. IC50 values of tyrosinase inhibition (A) and IC50 values of elastase inhib-
ition (B) obtained for the most active extracts. Different letters within the same
assay indicate significant differences in ANOVA test (p< 0.05). Results are
expressed ad means± SD of three independent experiments. COF: Ceterach offici-
narum DC.; CSI: Camellia sinensis Kuntze; CZE: Cinnamomum zeylanicum Nees; GBI:
Ginkgo biloba L.; GGL: Glycyrrhiza glabra L.; RNI: Ribes nigrum L.; ROF: Rheum offi-
cinale Baill.; RRO: Rhodiola rosea L.; SOF: Salvia officinalis L.; TPL: Tilia platyphyllos
Scop.; VVI: Vitis vinifera L.
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